期刊文献+

孕激素阻断方案在既往助孕失败患者中的应用

Endogerous and exogenous progesterone used to block the LH surge during ovarian stimulation in the patients who failed to get pregnancy in IVF/ICSI-ET cycles
在线阅读 下载PDF
导出
摘要 目的探讨既往采用常规降调节长方案行体外受精/卵泡浆内单精子注射-胚胎移植(IVF/ICSI-ET)助孕失败的卵巢正常反应患者,改用孕激素阻断方案的临床效果。方法回顾性分析2018年9月-2019年3月于珠海市妇幼保健院行孕激素阻断方案促排卵的患者资料,从中筛选出既往曾行长方案促排卵,鲜胚移植周期及冻融胚胎移植(FET)周期均未获活产的卵巢正常反应的不孕患者共52人的病历资料。对照两种方案的促排卵、胚胎情况以及妊娠结局。结果孕激素阻断方案中Gn用量(2079.81±534.08)U显著低于长方案(2716.82±825.09)U(P<0.05);获卵数、MⅡ卵率及正常受精率与长方案比较差异无显著统计学意义(P>0.05),可利用胚胎数(2.82±1.91)个显著高于长方案(1.49±1.42)个(P<0.05),优质胚胎率略高于长方案,但差异无统计学意义(P>0.05)。其中,20例患者行FET,生化妊娠7例,临床妊娠9例,周期临床妊娠率45.00%,胚胎种植率34.38%,活产率35.00%均显著高于长方案(分别为14.29%、8.47%、0.00%),差异有统计学意义(P<0.05)。结论对于常规长方案促排卵后IVF/ICSI助孕失败的卵巢正常反应患者,孕激素阻断方案可获得较好的临床妊娠结局,为促排卵治疗提供了一种新的选择方案。 Objective To explore the clinical effect of endogerous and exogenous progesterone used to block the LH surge during ovarian stimulation for IVF/ICSI in normal ovarian responders who failed to get live birth in the cycles with conventional long protocol.Methods The data of 52 normal ovarian responders who failed to get live birth with conventional long protocol,and then were administrated with endogerous and exogenous progesterone used to block the LH surge during ovarian stimulation as a new protocol in our center from Sep.2018 to Mar.2019 were analyzed retrospectively.The duration and the total dosage of gonadotropin(Gn)used,the number of oocytes retrieved,the rate of MⅡoocytes,fertilization and high quality embryos,the implantation rate,the clinical pregnancy rate and the live birth rate were compared between the two groups.Results The total dosage of Gn used[(2079.81±534.08)U vs.(2716.82±825.09)U]with progesterone used protocol were significantly less than those with conventional long protocol(P<0.05).Although the number of oocytes retrieved,the rate of MⅡoocytes and the fertilization rate were not significantly different(P>0.05),the number of available embryos[(2.82±1.91)vs.(1.49±1.42)]was significantly increased in progesterone used protocol cycles(P<0.05).The number of high quality embryos and the rate were increased in progesterone used protocol cycles,but there was no significant difference between the two groups(P>0.05).The clinical pregnancy rate(45.00%vs.14.29%),the implantation rate(34.38%vs.8.47%)and the live birth rate(35.00%vs.0.00%)were significantly improved in the FET cycles with progesterone used protocol(P<0.05).Conclusions The protocol that endogerous and exogenous progesterone used to block the LH surge during ovarian stimulation could provide better clinical outcomes for the patients with ovarian normal response but failed to get live birth with conventional long protocol in IVF/ICSI.It provides a new option for ovulation induction.
作者 郑华 许伟标 蔡桂丰 杨嫦玉 梁伟敏 ZHENG Hua;XU Wei Biao;CAI Gui Feng;YANG Chang Yu;LIANG Wei Min(Maternal and Child Health Care Hospital in Zhuhai,Zhuhai 519000,China)
出处 《中国妇幼卫生杂志》 2020年第4期67-71,共5页 Chinese Journal of Women and Children Health
关键词 长方案 孕激素 卵巢刺激 体外受精-胚胎移植 long protocol progesterone ovarian stimulation IVF-ET
作者简介 通信作者:蔡桂丰。
  • 相关文献

参考文献1

二级参考文献36

  • 1Macklon NS, Stouffer RL, Giudice LC, et al. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev, 2006, 27(2): 170-207.
  • 2Porter RN, Smith W, Craft IL, et al. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet, 1984, 2(8414):1284-5.
  • 3Fleming R, Adam AH, Barlow DH, et al. A new systematic treatment for infertile women with abnormal hormone profiles. Br J Obstet Gynaecol, 1982, 89(1):80-3.
  • 4Smitz J, Devroey P, Camus M, et al. The luteal phase and early pregnancy after combined GnRH-agonist/hMG treatment for superovulation in IVF or GIFT. Hum Reprod, 1988, 3 (5):585-90.
  • 5Huime JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod, 2007, 22(11):2805-13.
  • 6Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril, 2003, 80(6): 1444-9.
  • 7Reichman DE, Zakarin L, Chao K, et al. Diminished ovarian reserve is the predominant risk factor for gonadotropin-re- leasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.Fertil Steril, 2014,102(1):99-102.
  • 8Cedrin-Dumerin I, Bstndig B, Pameix I, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre- treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod, 2007, 22(1):109-16.
  • 9Kuang Y, Chen Q, Huang Q, et al. Luteal-phase ovarian stimulation case report: three-year follow-up of a twin birth. J IVF Reprod Med Genet, 2013, 1:106.
  • 10Kuang Y, Hong Q, Chen Q, et al. Luteal-phase ovarian stimu- lation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril, 2014, 101(1):105-11.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部